Canadian Cabinet Setback For Generics

31 December 1997

Canadian Prime Minister Jean Chretien has rejected federal HealthMinister Allan Rock's attempts to repeal the Notice Of Compliance regulations, under which brand-name manufacturers can prevent generic copies from being approved for up to 30 months by claiming patent infringement.

Following a cabinet battle between Mr Rock and Industry Minister John Manley which prevented any agreement on the issue being reached before Christmas, Mr Chretien handed the file to Mr Manley and told him to find a compromise solution.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight